Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neflamapimod in Early Alzheimer's Disease
NCT03435861Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neflamapimod in Alzheimer's disease (AD), sponsored by Centre hospitalier universitaire de Toulouse. Started Oct 2018; status: completed.
02
Drugs
neflamapimod
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03435861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03435861.